- Seventh Sense Biosystems receives a $10M funding round from a group of investors that includes Novartis (NYSE:NVS) and LabCorp (NYSE:LH). The Medford-MA-based firm is developing a disposable blood collection device called Touch Activated Phlebotomy which used microscopic needles to collect a fingerstick-sized blood sample.
- Controversial diagnostic start-up Theranos tried to develop a similar product before crashing amid investigations and failed operations.